CHI3L1 and synucleinopathy: It was reported that YKL-40 levels were decreased in synucleinopathies when compared with tauopathies, suggesting that glial activation may be lower in brains from PD patients and other synucleinopathies in comparison with patients who have tauopathies or healthy controls [26,56].